archivePharmaceuticals

India and Tanzania are taking significant steps to enhance their economic partnership by considering trade settlements in local currencies. This initiative aims to strengthen bilateral ties and ease the business operations between the two nations.During the India-Tanzania Joint Trade Committee meeting held in Dar es Salaam on April 29-30, 2026, senior officials, including India's Commerce Secretary Rajesh Agrawal and Tanzania's Permanent Secretary for the Ministry of Foreign Affairs Dr. Samwel William Shelukindo, explored multiple areas for cooperation. Key topics included long-term business visas for Indian entrepreneurs, regulatory collaboration in pharmaceuticals,...

INDIA - 2025/06/08: In this photo illustration, a Gilead Sciences logo is seen displayed on a ... More smartphone and in the background. (Photo Illustration by Avishek Das/SOPA Images/LightRocket via Getty Images)SOPA Images/LightRocket via Getty Images Despite a recent setback with an FDA clinical hold on its HIV treatment trials (GS-1720 and GS-4182) due to a decrease in CD4+ T-cells, Gilead Sciences (NASDAQ:GILD) has demonstrated a strong performance this year, with its stock up 18% compared to the S&P 500’s modest 2% gain. The company is actively collaborating with authorities...

CHONGQING, CHINA - OCTOBER 31: The Regeneron webpage is displayed on a smartphone in front of the ... More Regeneron Pharmaceuticals, Inc. logo on October 31, 2024 in Chongqing, China. (Photo by Cheng Xin/Getty Images)Getty Images Regeneron Pharmaceuticals (NASDAQ:REGN) shares witnessed a notable 19% decline on Friday, May 30, in the wake of the unexpected failure of itepekimab, its chronic obstructive pulmonary disease (COPD) treatment in conjunction with Sanofi, during a late-stage clinical trial. One of the two trials did not achieve its primary endpoint, which is a significant setback...